Scientific publications
Antibodies:
Blood. 2001 Oct 15;98(8): 2526-34.
Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody.
J Histochem Cytochem. 2001 Jul;49(7):911-7.
Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3).
Br J Cancer. 2000 Jul;83(2):261-6.
The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells.
J Immunol. 1999 Aug 1;163(3): 1246-52
Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing.
J Immunol. 1995 Jul 1;155(1):219-25.
Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies.
Cell Therapy:
J Virol. 2004 Jan 15;78(2):568-575.
Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides.
Langenbecks Arch Surg. 2003 Sep 18 [Epub ahead of print]
Tolerance-inducing strategies in transplantation surgery-current status and perspectives.
Stem Cells. 2003;21(4):428-36.
Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages.
J Mol Med. 2002 Jun;80(6):343-50. Epub 2002 May 16. Review.
Embryonic stem cells share immune-privileged features relevant for tolerance induction.
Nat Med. 2002 Feb;8(2):171-8.
Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning.
J Virol. 2001 Mar;75(6):3038-42.
Membrane-anchored peptide inhibits human immunodeficiency virus entry.